Vaxart, Inc. (VXRT)

OQX – Real vaqt narxi. Valyuta: USD

0.68

+0.03 (4.62%)

Yopilishda: May 12, 2026, 4:00 PM EDT

09.05.2026

Vaxart, Inc. (VXRT) Q1 2026 Earnings Call Transcript

07.05.2026

Vaxart Provides Business Update and Reports First Quarter 2026 Financial Results

Topline data from 400-person sentinel cohort of the Phase 2b COVID-19 trial anticipated in Q2 2026 Cash, cash equivalents, and investments of $61.0 million as of March 31, 2026; runway into second quarter of 2027 Live stockholder fireside chat scheduled for May 8, 2026 at 4:30 p.m. ET SOUTH SAN FRANCISCO, Calif.

23.04.2026

Vaxart Appoints James Breitmeyer, M.D., Ph.D., to Board of Directors

Appointment strengthens Board's clinical development and regulatory expertise as Vaxart advances its oral vaccine platform

17.04.2026

Vaxart Announces Share Purchase Agreement for up to $25 Million with Lincoln Park Capital

SOUTH SAN FRANCISCO, Calif., April 17, 2026 (GLOBE NEWSWIRE) -- Vaxart, Inc. (OTCQX: VXRT) (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing a range of oral vaccines based on its proprietary delivery platform, today announced that it has entered into a share purchase agreement (SPA) with Lincoln Park Capital Fund.

14.03.2026

Vaxart, Inc. (VXRT) Shareholder/Analyst Call Transcript

12.03.2026

Vaxart, Inc. (VXRT) Q4 2025 Earnings Call Transcript

03.03.2026

Vaxart to Host Upcoming Conference Calls

Full year 2025 business update and financial results conference call to be held March 12 at 4:30 p.m. ET Stockholder fireside chat to be held on March 13 at 4:30 p.m.

Videolar

No Data

There is no data to display

Press-relizlar

07.05.2026

Vaxart Provides Business Update and Reports First Quarter 2026 Financial Results

23.04.2026

Vaxart Appoints James Breitmeyer, M.D., Ph.D., to Board of Directors

Appointment strengthens Board's clinical development and regulatory expertise as Vaxart advances its oral vaccine platform

17.04.2026

Vaxart Announces Share Purchase Agreement for up to $25 Million with Lincoln Park Capital

09.02.2026

Hagens Berman Sobol Shapiro LLP and Scott+Scott Attorneys at Law LLP Announce a Class Action for All Vaxart Shareholders that May Include You, Even if You Participated in the Previous Partial Settlement with Vaxart

NEW YORK--(BUSINESS WIRE)--Hagens Berman Sobol Shapiro LLP & Scott+Scott Attorneys at Law LLP: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA In re VAXART, INC. SECURITIES LITIGATION This Document Relates to: ALL ACTIONS Master Case No. 3:20-cv-05949-VC SUPPLEMENTAL SUMMARY NOTICE OF CLASS CERTIFICATION THIS SUPPLEMENTAL NOTICE PROVIDES ONLY LIMITED INFORMATION ABOUT THE CASE PLEASE VISIT WWW.VAXARTSECURITIESLITIGATION.COM FOR MORE INFORMATION The Court has certified this laws.

Vaxart, Inc. (VXRT)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Vaxart, Inc. (VXRT)

Vaxart, Inc. (VXRT) Q1 2026 Earnings Call Transcript

Vaxart Provides Business Update and Reports First Quarter 2026 Financial Results

Vaxart Appoints James Breitmeyer, M.D., Ph.D., to Board of Directors

Vaxart Announces Share Purchase Agreement for up to $25 Million with Lincoln Park Capital

Vaxart, Inc. (VXRT) Shareholder/Analyst Call Transcript

Vaxart, Inc. (VXRT) Q4 2025 Earnings Call Transcript

Vaxart to Host Upcoming Conference Calls

Videolar

No Data

Press-relizlar

Vaxart Provides Business Update and Reports First Quarter 2026 Financial Results

Vaxart Appoints James Breitmeyer, M.D., Ph.D., to Board of Directors

Vaxart Announces Share Purchase Agreement for up to $25 Million with Lincoln Park Capital

Hagens Berman Sobol Shapiro LLP and Scott+Scott Attorneys at Law LLP Announce a Class Action for All Vaxart Shareholders that May Include You, Even if You Participated in the Previous Partial Settlement with Vaxart

Vaxart, Inc. (VXRT) Q1 2026 Earnings Call Transcript

Vaxart Provides Business Update and Reports First Quarter 2026 Financial Results

Vaxart Appoints James Breitmeyer, M.D., Ph.D., to Board of Directors

Vaxart Announces Share Purchase Agreement for up to $25 Million with Lincoln Park Capital

Vaxart, Inc. (VXRT) Shareholder/Analyst Call Transcript

Vaxart, Inc. (VXRT) Q4 2025 Earnings Call Transcript

Vaxart to Host Upcoming Conference Calls

Videolar

No Data

Press-relizlar

Vaxart Provides Business Update and Reports First Quarter 2026 Financial Results

Vaxart Appoints James Breitmeyer, M.D., Ph.D., to Board of Directors

Vaxart Announces Share Purchase Agreement for up to $25 Million with Lincoln Park Capital

Hagens Berman Sobol Shapiro LLP and Scott+Scott Attorneys at Law LLP Announce a Class Action for All Vaxart Shareholders that May Include You, Even if You Participated in the Previous Partial Settlement with Vaxart

Search stocks

Vaxart, Inc. (VXRT)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Vaxart, Inc. (VXRT)

Vaxart, Inc. (VXRT) Q1 2026 Earnings Call Transcript

Vaxart Provides Business Update and Reports First Quarter 2026 Financial Results

Vaxart Appoints James Breitmeyer, M.D., Ph.D., to Board of Directors

Vaxart Announces Share Purchase Agreement for up to $25 Million with Lincoln Park Capital

Vaxart, Inc. (VXRT) Shareholder/Analyst Call Transcript

Vaxart, Inc. (VXRT) Q4 2025 Earnings Call Transcript

Vaxart to Host Upcoming Conference Calls

Videolar

No Data

Press-relizlar

Vaxart Provides Business Update and Reports First Quarter 2026 Financial Results

Vaxart Appoints James Breitmeyer, M.D., Ph.D., to Board of Directors

Vaxart Announces Share Purchase Agreement for up to $25 Million with Lincoln Park Capital

Hagens Berman Sobol Shapiro LLP and Scott+Scott Attorneys at Law LLP Announce a Class Action for All Vaxart Shareholders that May Include You, Even if You Participated in the Previous Partial Settlement with Vaxart

Vaxart, Inc. (VXRT) Q1 2026 Earnings Call Transcript

Vaxart Provides Business Update and Reports First Quarter 2026 Financial Results

Vaxart Appoints James Breitmeyer, M.D., Ph.D., to Board of Directors

Vaxart Announces Share Purchase Agreement for up to $25 Million with Lincoln Park Capital

Vaxart, Inc. (VXRT) Shareholder/Analyst Call Transcript

Vaxart, Inc. (VXRT) Q4 2025 Earnings Call Transcript

Vaxart to Host Upcoming Conference Calls

Videolar

No Data

Press-relizlar

Vaxart Provides Business Update and Reports First Quarter 2026 Financial Results

Vaxart Appoints James Breitmeyer, M.D., Ph.D., to Board of Directors

Vaxart Announces Share Purchase Agreement for up to $25 Million with Lincoln Park Capital

Hagens Berman Sobol Shapiro LLP and Scott+Scott Attorneys at Law LLP Announce a Class Action for All Vaxart Shareholders that May Include You, Even if You Participated in the Previous Partial Settlement with Vaxart